Health ❯ Healthcare ❯ Clinical Trials
Patient Outcomes Phase 3 Trials Lecanemab Weight Loss Efficacy Phase 2 Trials Progression-Free Survival OASIS 4 Trial Lecanemab Trials Orforglipron Lenacapavir Efficacy Weight Loss Medications STEP UP Trial Weight Loss Outcomes PURPOSE Trials SELECT Trial Results CAPELLA Trial SUMMIT Trial Lecanemab Efficacy Lecanemab Trial Results Miplyffa Home Treatment Options Non-Inferiority Trials Phase II Trials Obesity Treatments Hormone Receptor-Positive Cancer Drug Comparisons AUGMENT-101 Trial Late-Stage Trials Amycretin Trials mNEXSPIKE Vaccine Simplify-1 Study Phase IIb/III Trials TRANSCEND FL Study Beamion LUNG-1 Trial Placebo-Controlled Trials Phase-3 Trials H3 K27M Mutations Tirzepatide vs Dulaglutide FRESCO Trials LUNA 3 Study Wegovy Oral Orforglipron vs Semaglutide Cagrilintide Analytical Testing Weight Management CheckMate 67T POETYK PsA Trials Minoxidil Absorption QWINT Trials SURMOUNT and SURPASS STEP Program Lecanemabe Drug Side Effects STEP UP Trials MATTERHORN Trial Lenacapavir MONARCH 2 Trial MONARCH 3 Trial Asthma Exacerbations Semaglutide Trials Weight Loss Drugs Acalabrutinib and Bendamustine-Rituximab DREAMM-8 Trial Long-term Data Randomized Trials ACCESS Program Antibody Response Pediatric Oncology ONWARDS Program DEVOTE Study Edison Histotripsy System JUPITER-02 Trial Weight Loss Trials ATTAIN-1 Trial Adverse Events Rezafungin Protein Therapy OLYMPIA Trials Obefazimod Nature Medicine Publication LITESPARK-022 Trial Weight Loss Treatments VALOR Trial
Regulators cited phase 3 VALOR data showing sustained muscle and skin benefit, with the drug’s label carrying a boxed warning for serious infections, cardiovascular events, cancer, and thrombosis.